CB2 receptor agonist 2

CAS No. 1314230-75-5

CB2 receptor agonist 2( 4-Quinolone-3-Carboxamide Furan CB2 Agonist | ZINC72105556 )

Catalog No. M27495 CAS No. 1314230-75-5

CB2 receptor agonist 2 is a potent and selective agonist for the CB2 (cannabinoid type 2) receptor, Ki = 8.5 nM. CB2 receptor agonist 2 has high affinity and selectivity for CB2.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 169 In Stock
5MG 267 In Stock
10MG 391 In Stock
25MG 616 In Stock
50MG 809 In Stock
100MG 1088 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CB2 receptor agonist 2
  • Note
    Research use only, not for human use.
  • Brief Description
    CB2 receptor agonist 2 is a potent and selective agonist for the CB2 (cannabinoid type 2) receptor, Ki = 8.5 nM. CB2 receptor agonist 2 has high affinity and selectivity for CB2.
  • Description
    CB2 receptor agonist 2 is a potent and selective agonist for the CB2 (cannabinoid type 2) receptor, Ki = 8.5 nM. CB2 receptor agonist 2 has high affinity and selectivity for CB2.(In Vitro):CB2 receptor agonist 2 (compound 4g) (1 μM; 72 hours) shows low or no cytotoxicity to Hep-G2 cells.(In Vivo):CB2 receptor agonist 2 (compound 4g) (1 and 3 mg/kg; 1 hour) is very potent (with maximal effect being reached already at the 1 mg/kg dose) and has antihyperalgesic effects, efficacious also on the first phase of the nocifensive response and strongly reduced by AM630, a CB2-selective antagonist/inverse agonist .
  • In Vitro
    CB2 receptor agonist 2 (compound 4g) (1 ?μM; 72 hours) has very low or no cytotoxicity to Hep-G2 cells. Cell Proliferation Assay Cell Line:Hep-G2 (Human hepatoblastoma) cells Concentration:1 ?μM Incubation Time:72 hours Result:Exhibited very low or no cytotoxicity to Hep-G2 cells.
  • In Vivo
    CB2 receptor agonist 2 (compound 4g) (1 and 3 mg/kg; 1 hour) is very potent (with maximal effect being reached already at the 1 mg/kg dose) and has antihyperalgesic effects, efficacious also on the first phase of the nocifensive response and strongly reduced by AM630 (CB2-selective antagonist/inverse agonist) . Animal Model:Formalin injection induces a biphasic stereotypical nocifensive behavior in miceDosage:Formalin (1.25% in saline, 30 μL), 1 and 3 mg/kg CB2 receptor agonist 2, 1 mg/kg AM630, monitor every 5 minutes for 1 hour Administration:Injection in the dorsal surface of one side of the hindpaw (Formalin), i.p. (CB2 receptor agonist, AM630)Result:Elicited antihyperalgesic effects and potent (with maximal effect being reached already at the 1 mg/kg dose) and efficacious, strongly reduced by AM630.
  • Synonyms
    4-Quinolone-3-Carboxamide Furan CB2 Agonist | ZINC72105556
  • Pathway
    GPCR/G Protein
  • Target
    Cannabinoid Receptor
  • Recptor
    Trypanosoma cruzi
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1314230-75-5
  • Formula Weight
    488.62
  • Molecular Formula
    C30H36N2O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(NC12CC3CC(CC(C3)C1)C2)C4=CN(C=5C(OC)=CC(=CC5C4=O)C=6OC=CC6)CCCCC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Souza DCS, et al. Simplified Derivatives of Dibenzylbutyrolactone Lignans from Hydrocotyle bonariensis as Antitrypanosomal Candidates. Chem Biodivers. 2021 Oct;18(10):e2100515.
molnova catalog
related products
  • AM-1221

    A potent and selective agonist for the cannabinoid receptor CB1 with Ki of 0.28 nM, 180-fold selectivity over CB2.

  • SMM-295

    A novel potent, selective cannabinoid receptor 2 (CB2) agonist with Ki of 12 nM.

  • Tetrahydromagnolol

    Tetrahydromagnolol can activate cannabinoid (CB) receptors.